Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4130858 | Current Diagnostic Pathology | 2007 | 10 Pages |
Abstract
SummaryNeoadjuvant therapy is increasingly used in the treatment of gastrointestinal malignancies. New molecular target-specific agents also have a role in downstaging hepatic colorectal metastases and metastatic gastrointestinal stromal tumours. Pathologists need to be familiar with post-treatment changes and with tumour regression grading systems. Accurate assessment of specimens is crucial for prognostic purposes and to evaluate therapeutic response. A standardized pathological approach is recommended.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pathology and Medical Technology
Authors
Lai Mun Wang, Kieran Sheahan,